BSN 315 HESI RN Specialty Pharmacology Exam V3 (2026/2027) Nightingale College
BSN 315 HESI RN SPECIALTY PHARMACOLOGY EXAM V3
(LATEST UPDATE ) QUESTIONS & ANSWERS
100% CORRECT | GRADE A - NIGHTINGALE
Aligned with the Nightingale College BSN 315 Course Syllabus, HESI RN Specialty Exam Blueprint, NCLEX-RN Test Plan,
and Nursing Pharmacology Standards ( Edition).
EXAMINATION OVERVIEW
Total Questions: 150 | Sections: 9 | Cognitive Levels: 20% Recall, 50% Application, 30% Analysis
Question Style: 75% Scenario-Based | 25% Direct Knowledge
Format: Multiple Choice (A-D, one correct answer per item)
Each question includes the correct answer and a 2-4 sentence rationale grounded in the BSN 315 curriculum, HESI RN
Specialty standards, and NCLEX-RN pharmacology references.
EXAMINATION SECTIONS
Section 1: Pharmacokinetics & Pharmacodynamics (Q1-Q20)
Section 2: Medication Safety & Administration (Q21-Q40)
Section 3: Dosage Calculations & Medication Math (Q41-Q60)
Section 4: Cardiovascular Pharmacology (Q61-Q80)
Section 5: Respiratory Pharmacology (Q81-Q95)
Section 6: Endocrine Pharmacology (Q96-Q110)
Section 7: Gastrointestinal & Renal Pharmacology (Q111-Q125)
Section 8: Neurological & Psychopharmacology (Q126-Q140)
Section 9: Anti-infective Pharmacology (Q141-Q150)
INSTRUCTIONS: Select the SINGLE best answer for each question. The correct answer is marked *[CORRECT]* with a
2-4 sentence rationale.
Page 1
100% Correct | Grade A - For BSN 315 HESI RN Specialty Preparation
,BSN 315 HESI RN Specialty Pharmacology Exam V3 (2026/2027) Nightingale College
Section 1: Pharmacokinetics & Pharmacodynamics
(20 Questions)
Q1: A 68-year-old patient with hepatic cirrhosis is prescribed a medication that undergoes extensive
first-pass metabolism. The provider orders the medication via the oral route. Which nursing action is most
appropriate based on pharmacokinetic principles?
A. Administer the medication as ordered and monitor for therapeutic effects.
B. Hold the dose and clarify with the provider about an alternative non-oral route. *[CORRECT]*
C. Administer a double dose to compensate for the first-pass loss.
D. Crush the tablet to bypass the first-pass effect.
Correct Answer: B
Rationale: In hepatic impairment, the first-pass effect is reduced, leading to higher bioavailability of orally
administered drugs and increased risk of toxicity. Per BSN 315 pharmacokinetics standards, the nurse should clarify
alternative routes (e.g., sublingual, transdermal, or IV) that bypass hepatic first-pass metabolism. Crushing the tablet
does not bypass the liver, and doubling the dose is unsafe.
Q2: A patient receives a drug with a half-life of 8 hours. The medication is ordered every 8 hours.
Approximately how long will it take for the medication to reach steady state?
A. 8 hours
B. 16 hours
C. 32 to 40 hours *[CORRECT]*
D. 72 hours
Correct Answer: C
Rationale: Steady state is achieved after approximately 4 to 5 half-lives. With a half-life of 8 hours, steady state
occurs at 32 to 40 hours (4 x 8 = 32; 5 x 8 = 40). Per HESI RN pharmacology standards, this concept is critical for
evaluating therapeutic drug levels and timing laboratory draws. The other options do not reflect the 4-5 half-life rule.
Q3: A patient is started on a loading dose of phenytoin followed by a maintenance dose. What is the
primary purpose of administering a loading dose?
A. To minimize adverse effects of the medication
B. To rapidly achieve therapeutic drug levels *[CORRECT]*
C. To extend the drug's half-life
D. To reduce the total daily dose required
Correct Answer: B
Rationale: A loading dose is a high initial dose used to rapidly achieve therapeutic plasma concentrations,
particularly for drugs with long half-lives (like phenytoin). Per NCLEX-RN pharmacology test plan, this is essential
when waiting for steady state would be clinically dangerous. Maintenance doses sustain the level but cannot rapidly
establish it. Loading doses do not minimize side effects-in fact, they may increase risk.
Q4: A patient taking warfarin (highly protein-bound) is started on sulfamethoxazole-trimethoprim, which
also binds albumin. Which effect is most likely to occur?
A. Increased free warfarin leading to elevated INR and bleeding risk *[CORRECT]*
B. Decreased warfarin effectiveness due to rapid excretion
C. No significant change because the body compensates
D. Increased warfarin metabolism by hepatic enzymes
Page 2
100% Correct | Grade A - For BSN 315 HESI RN Specialty Preparation
,BSN 315 HESI RN Specialty Pharmacology Exam V3 (2026/2027) Nightingale College
Correct Answer: A
Rationale: Warfarin is highly protein-bound (>99%). When a competing drug like sulfamethoxazole displaces
warfarin from albumin, free (active) warfarin increases, raising INR and bleeding risk. Per BSN 315 drug interaction
standards, this is a classic displacement interaction. Option B is incorrect because excretion is not directly altered.
The body cannot fully compensate acutely. Option D describes enzyme induction, not displacement.
Q5: A nurse is caring for a patient receiving IV morphine. The patient asks why IV morphine works faster
than oral morphine. Which pharmacokinetic concept best explains this?
A. Distribution to the brain is enhanced by the oral route
B. IV administration bypasses first-pass metabolism and absorption barriers *[CORRECT]*
C. IV morphine has a longer half-life than oral morphine
D. Oral morphine has 100% bioavailability
Correct Answer: B
Rationale: IV administration provides 100% bioavailability directly into systemic circulation, bypassing absorption
barriers and hepatic first-pass metabolism. This results in faster onset. Per HESI RN pharmacology blueprint, oral
bioavailability of morphine is only about 25-30% due to first-pass loss. Options C and D are incorrect: half-life is
route-independent, and oral bioavailability is not 100%.
Q6: A patient with chronic kidney disease has a reduced glomerular filtration rate (GFR). Which
pharmacokinetic phase is most directly affected, increasing the risk of drug toxicity?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion *[CORRECT]*
Correct Answer: D
Rationale: Renal impairment reduces drug excretion, causing accumulation of renally cleared drugs (e.g., digoxin,
vancomycin, aminoglycosides) and toxicity. Per BSN 315 NCLEX standards, the excretion phase is most directly
affected by low GFR. Absorption occurs in the GI tract, metabolism in the liver, and distribution via blood flow-none of
which are primarily dependent on GFR.
Q7: Which drug has a narrow therapeutic index, requiring routine serum drug level monitoring?
A. Acetaminophen
B. Ibuprofen
C. Digoxin *[CORRECT]*
D. Metformin
Correct Answer: C
Rationale: Digoxin has a narrow therapeutic index (0.5 to 2 ng/mL). Toxicity can occur at levels only slightly above
therapeutic. Per HESI RN pharmacology standards, serum digoxin levels must be monitored, and the nurse must
assess for bradycardia, visual disturbances (yellow-green halos), and GI complaints. The other medications have
wider safety margins and do not require routine serum monitoring.
Q8: A patient asks the nurse about agonists and antagonists. Which statement by the nurse is correct?
A. An agonist blocks the receptor and prevents any response.
B. An antagonist binds to a receptor and produces a therapeutic effect.
C. An agonist binds to a receptor and produces a therapeutic response. *[CORRECT]*
Page 3
100% Correct | Grade A - For BSN 315 HESI RN Specialty Preparation
, BSN 315 HESI RN Specialty Pharmacology Exam V3 (2026/2027) Nightingale College
D. An antagonist has higher efficacy than an agonist.
Correct Answer: C
Rationale: An agonist binds to a receptor and activates it, producing a therapeutic response (e.g., morphine at mu
receptors). An antagonist binds to a receptor without activating it, blocking endogenous or exogenous agonists (e.g.,
naloxone blocking morphine). Per NCLEX-RN pharmacology test plan, this distinction is fundamental. Efficacy refers
to maximum response, not whether a drug is an agonist or antagonist.
Q9: A patient taking phenytoin is started on carbamazepine, a known CYP450 enzyme inducer. What
effect will this have on phenytoin?
A. Increased phenytoin levels and toxicity risk
B. Decreased phenytoin levels and possible seizure breakthrough *[CORRECT]*
C. No effect on phenytoin metabolism
D. Enhanced phenytoin absorption
Correct Answer: B
Rationale: CYP450 enzyme inducers (e.g., carbamazepine, rifampin, phenytoin itself) accelerate metabolism of
other drugs, lowering their plasma levels. Per BSN 315 drug interaction curriculum, this can lead to subtherapeutic
phenytoin and seizure breakthrough. Option A describes enzyme inhibitors (e.g., erythromycin, ketoconazole).
Inducers do not affect absorption.
Q10: A patient receives a medication that is a weak acid. The patient's urine is alkaline (pH 8). How will
this affect the drug's excretion?
A. Increased reabsorption and decreased excretion
B. Increased ionization, decreased reabsorption, and increased excretion *[CORRECT]*
C. No effect on excretion
D. The drug will be metabolized instead of excreted
Correct Answer: B
Rationale: Weak acids are ionized in alkaline environments. Ionized drugs cannot cross renal tubular membranes
easily, so they are trapped in urine and excreted. This principle is used for salicylate overdose (alkaline diuresis with
sodium bicarbonate). Per HESI RN standards, weak bases are excreted faster in acidic urine. Options A, C, D reflect
misconceptions.
Q11: A patient receiving long-term opioid therapy requires increasing doses to achieve the same pain
relief. Which pharmacologic concept explains this?
A. Addiction
B. Pseudoaddiction
C. Tolerance *[CORRECT]*
D. Dependence
Correct Answer: C
Rationale: Tolerance is a pharmacologic adaptation in which chronic exposure to a drug results in diminished
response, requiring higher doses to achieve the same effect. Per BSN 315 pharmacodynamics curriculum, this is
physiologic, not behavioral. Addiction involves compulsive use despite harm. Dependence is manifested by
withdrawal upon discontinuation. Pseudoaddiction describes under-treated pain mimicking addictive behavior.
Q12: A patient develops anaphylaxis after the first dose of penicillin. Which type of adverse drug reaction
is this?
Page 4
100% Correct | Grade A - For BSN 315 HESI RN Specialty Preparation
BSN 315 HESI RN SPECIALTY PHARMACOLOGY EXAM V3
(LATEST UPDATE ) QUESTIONS & ANSWERS
100% CORRECT | GRADE A - NIGHTINGALE
Aligned with the Nightingale College BSN 315 Course Syllabus, HESI RN Specialty Exam Blueprint, NCLEX-RN Test Plan,
and Nursing Pharmacology Standards ( Edition).
EXAMINATION OVERVIEW
Total Questions: 150 | Sections: 9 | Cognitive Levels: 20% Recall, 50% Application, 30% Analysis
Question Style: 75% Scenario-Based | 25% Direct Knowledge
Format: Multiple Choice (A-D, one correct answer per item)
Each question includes the correct answer and a 2-4 sentence rationale grounded in the BSN 315 curriculum, HESI RN
Specialty standards, and NCLEX-RN pharmacology references.
EXAMINATION SECTIONS
Section 1: Pharmacokinetics & Pharmacodynamics (Q1-Q20)
Section 2: Medication Safety & Administration (Q21-Q40)
Section 3: Dosage Calculations & Medication Math (Q41-Q60)
Section 4: Cardiovascular Pharmacology (Q61-Q80)
Section 5: Respiratory Pharmacology (Q81-Q95)
Section 6: Endocrine Pharmacology (Q96-Q110)
Section 7: Gastrointestinal & Renal Pharmacology (Q111-Q125)
Section 8: Neurological & Psychopharmacology (Q126-Q140)
Section 9: Anti-infective Pharmacology (Q141-Q150)
INSTRUCTIONS: Select the SINGLE best answer for each question. The correct answer is marked *[CORRECT]* with a
2-4 sentence rationale.
Page 1
100% Correct | Grade A - For BSN 315 HESI RN Specialty Preparation
,BSN 315 HESI RN Specialty Pharmacology Exam V3 (2026/2027) Nightingale College
Section 1: Pharmacokinetics & Pharmacodynamics
(20 Questions)
Q1: A 68-year-old patient with hepatic cirrhosis is prescribed a medication that undergoes extensive
first-pass metabolism. The provider orders the medication via the oral route. Which nursing action is most
appropriate based on pharmacokinetic principles?
A. Administer the medication as ordered and monitor for therapeutic effects.
B. Hold the dose and clarify with the provider about an alternative non-oral route. *[CORRECT]*
C. Administer a double dose to compensate for the first-pass loss.
D. Crush the tablet to bypass the first-pass effect.
Correct Answer: B
Rationale: In hepatic impairment, the first-pass effect is reduced, leading to higher bioavailability of orally
administered drugs and increased risk of toxicity. Per BSN 315 pharmacokinetics standards, the nurse should clarify
alternative routes (e.g., sublingual, transdermal, or IV) that bypass hepatic first-pass metabolism. Crushing the tablet
does not bypass the liver, and doubling the dose is unsafe.
Q2: A patient receives a drug with a half-life of 8 hours. The medication is ordered every 8 hours.
Approximately how long will it take for the medication to reach steady state?
A. 8 hours
B. 16 hours
C. 32 to 40 hours *[CORRECT]*
D. 72 hours
Correct Answer: C
Rationale: Steady state is achieved after approximately 4 to 5 half-lives. With a half-life of 8 hours, steady state
occurs at 32 to 40 hours (4 x 8 = 32; 5 x 8 = 40). Per HESI RN pharmacology standards, this concept is critical for
evaluating therapeutic drug levels and timing laboratory draws. The other options do not reflect the 4-5 half-life rule.
Q3: A patient is started on a loading dose of phenytoin followed by a maintenance dose. What is the
primary purpose of administering a loading dose?
A. To minimize adverse effects of the medication
B. To rapidly achieve therapeutic drug levels *[CORRECT]*
C. To extend the drug's half-life
D. To reduce the total daily dose required
Correct Answer: B
Rationale: A loading dose is a high initial dose used to rapidly achieve therapeutic plasma concentrations,
particularly for drugs with long half-lives (like phenytoin). Per NCLEX-RN pharmacology test plan, this is essential
when waiting for steady state would be clinically dangerous. Maintenance doses sustain the level but cannot rapidly
establish it. Loading doses do not minimize side effects-in fact, they may increase risk.
Q4: A patient taking warfarin (highly protein-bound) is started on sulfamethoxazole-trimethoprim, which
also binds albumin. Which effect is most likely to occur?
A. Increased free warfarin leading to elevated INR and bleeding risk *[CORRECT]*
B. Decreased warfarin effectiveness due to rapid excretion
C. No significant change because the body compensates
D. Increased warfarin metabolism by hepatic enzymes
Page 2
100% Correct | Grade A - For BSN 315 HESI RN Specialty Preparation
,BSN 315 HESI RN Specialty Pharmacology Exam V3 (2026/2027) Nightingale College
Correct Answer: A
Rationale: Warfarin is highly protein-bound (>99%). When a competing drug like sulfamethoxazole displaces
warfarin from albumin, free (active) warfarin increases, raising INR and bleeding risk. Per BSN 315 drug interaction
standards, this is a classic displacement interaction. Option B is incorrect because excretion is not directly altered.
The body cannot fully compensate acutely. Option D describes enzyme induction, not displacement.
Q5: A nurse is caring for a patient receiving IV morphine. The patient asks why IV morphine works faster
than oral morphine. Which pharmacokinetic concept best explains this?
A. Distribution to the brain is enhanced by the oral route
B. IV administration bypasses first-pass metabolism and absorption barriers *[CORRECT]*
C. IV morphine has a longer half-life than oral morphine
D. Oral morphine has 100% bioavailability
Correct Answer: B
Rationale: IV administration provides 100% bioavailability directly into systemic circulation, bypassing absorption
barriers and hepatic first-pass metabolism. This results in faster onset. Per HESI RN pharmacology blueprint, oral
bioavailability of morphine is only about 25-30% due to first-pass loss. Options C and D are incorrect: half-life is
route-independent, and oral bioavailability is not 100%.
Q6: A patient with chronic kidney disease has a reduced glomerular filtration rate (GFR). Which
pharmacokinetic phase is most directly affected, increasing the risk of drug toxicity?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion *[CORRECT]*
Correct Answer: D
Rationale: Renal impairment reduces drug excretion, causing accumulation of renally cleared drugs (e.g., digoxin,
vancomycin, aminoglycosides) and toxicity. Per BSN 315 NCLEX standards, the excretion phase is most directly
affected by low GFR. Absorption occurs in the GI tract, metabolism in the liver, and distribution via blood flow-none of
which are primarily dependent on GFR.
Q7: Which drug has a narrow therapeutic index, requiring routine serum drug level monitoring?
A. Acetaminophen
B. Ibuprofen
C. Digoxin *[CORRECT]*
D. Metformin
Correct Answer: C
Rationale: Digoxin has a narrow therapeutic index (0.5 to 2 ng/mL). Toxicity can occur at levels only slightly above
therapeutic. Per HESI RN pharmacology standards, serum digoxin levels must be monitored, and the nurse must
assess for bradycardia, visual disturbances (yellow-green halos), and GI complaints. The other medications have
wider safety margins and do not require routine serum monitoring.
Q8: A patient asks the nurse about agonists and antagonists. Which statement by the nurse is correct?
A. An agonist blocks the receptor and prevents any response.
B. An antagonist binds to a receptor and produces a therapeutic effect.
C. An agonist binds to a receptor and produces a therapeutic response. *[CORRECT]*
Page 3
100% Correct | Grade A - For BSN 315 HESI RN Specialty Preparation
, BSN 315 HESI RN Specialty Pharmacology Exam V3 (2026/2027) Nightingale College
D. An antagonist has higher efficacy than an agonist.
Correct Answer: C
Rationale: An agonist binds to a receptor and activates it, producing a therapeutic response (e.g., morphine at mu
receptors). An antagonist binds to a receptor without activating it, blocking endogenous or exogenous agonists (e.g.,
naloxone blocking morphine). Per NCLEX-RN pharmacology test plan, this distinction is fundamental. Efficacy refers
to maximum response, not whether a drug is an agonist or antagonist.
Q9: A patient taking phenytoin is started on carbamazepine, a known CYP450 enzyme inducer. What
effect will this have on phenytoin?
A. Increased phenytoin levels and toxicity risk
B. Decreased phenytoin levels and possible seizure breakthrough *[CORRECT]*
C. No effect on phenytoin metabolism
D. Enhanced phenytoin absorption
Correct Answer: B
Rationale: CYP450 enzyme inducers (e.g., carbamazepine, rifampin, phenytoin itself) accelerate metabolism of
other drugs, lowering their plasma levels. Per BSN 315 drug interaction curriculum, this can lead to subtherapeutic
phenytoin and seizure breakthrough. Option A describes enzyme inhibitors (e.g., erythromycin, ketoconazole).
Inducers do not affect absorption.
Q10: A patient receives a medication that is a weak acid. The patient's urine is alkaline (pH 8). How will
this affect the drug's excretion?
A. Increased reabsorption and decreased excretion
B. Increased ionization, decreased reabsorption, and increased excretion *[CORRECT]*
C. No effect on excretion
D. The drug will be metabolized instead of excreted
Correct Answer: B
Rationale: Weak acids are ionized in alkaline environments. Ionized drugs cannot cross renal tubular membranes
easily, so they are trapped in urine and excreted. This principle is used for salicylate overdose (alkaline diuresis with
sodium bicarbonate). Per HESI RN standards, weak bases are excreted faster in acidic urine. Options A, C, D reflect
misconceptions.
Q11: A patient receiving long-term opioid therapy requires increasing doses to achieve the same pain
relief. Which pharmacologic concept explains this?
A. Addiction
B. Pseudoaddiction
C. Tolerance *[CORRECT]*
D. Dependence
Correct Answer: C
Rationale: Tolerance is a pharmacologic adaptation in which chronic exposure to a drug results in diminished
response, requiring higher doses to achieve the same effect. Per BSN 315 pharmacodynamics curriculum, this is
physiologic, not behavioral. Addiction involves compulsive use despite harm. Dependence is manifested by
withdrawal upon discontinuation. Pseudoaddiction describes under-treated pain mimicking addictive behavior.
Q12: A patient develops anaphylaxis after the first dose of penicillin. Which type of adverse drug reaction
is this?
Page 4
100% Correct | Grade A - For BSN 315 HESI RN Specialty Preparation
